Propoxyphene Napsylate And Acetaminophen
Product Images NDC 67296-0105

6 FDA label images from Redpharm Drug Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Propoxyphene Napsylate And Acetaminophen (NDC 67296-0105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image1)

Structural Formula (Image1)
Chemical structure diagram of propoxyphene napsylate and acetaminophen, showing molecular formula C22H29NO2·C10H8O3S·H2O with a molecular weight of 565.72.*
FDA Label Image

Structural Formula (Image2)

Structural Formula (Image2)
Chemical structure diagram showing the molecular formula C8H9NO2 and a molecular weight of 151.16, representing the active ingredient from the product PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN by RedPharm Drug Inc. The diagram includes a benzene ring with hydroxyl and amide functional groups.*
FDA Label Image

Structural Formula (Image3)

Structural Formula (Image3)
A line graph titled Figure 1 showing mean plasma propoxyphene concentration (mcg/L) over 6 hours. It compares concentrations for different doses of propoxyphene HCl (65 mg, 130 mg, 195 mg) and propoxyphene napsylate (100 mg, 200 mg, 300 mg). The graph depicts higher concentrations for higher doses and differences between the two propoxyphene forms over time.*
FDA Label Image

Figure 2 (Image4)

Figure 2 (Image4)
A data table titled 'Acute Oral Toxicity of Propoxyphene' presenting LD50 values (mg/kg and mmol/kg) with standard error for propoxyphene hydrochloride and propoxyphene napsylate in mouse, rat, rabbit, and dog species.*
FDA Label Image

Figure 3 (Image5)

Figure 3 (Image5)
A line graph comparing plasma propoxyphene concentration (mg/L) over time (hours) following administration of propoxyphene hydrochloride 60 mg/kg and propoxyphene napsylate 97 mg/kg. The graph shows time on the x-axis (0.5 to 12 hours) and concentration on the y-axis (0.0 to 1.6 mg/L) with data points and error bars for each formulation.*
FDA Label Image

Copy Of Label (Image6)

Copy Of Label (Image6)
Label of PROPOXYPHENE NAPSYLATE and ACETAMINOPHEN 100 mg / 650 mg tablets. The package contains 15 tablets and is Rx only. Manufactured by Mallinckrodt Inc., St. Louis, MO, and distributed by Redpharm Drug, Minnetonka, MN. Storage instructions specify controlled room temperature (15-30°C/59-86°F). Barcode and lot number E16133 1 with expiration date 10/05 are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.